New Hepatitis NSW CEO Announced

HomeThe Hep-VineNew Hepatitis NSW CEO Announced

Steven DrewBoard President, Dr Denise Jarratt, has announced that Mr Steven Drew has been appointed as the new CEO of Hepatitis NSW, commencing on 1 October 2019.

Steven has held a number of senior appointments throughout his career. These include ten years as CEO of the Pharmaceutical Society of NSW and of the Pharmaceutical Society of Australia Limited (NSW Branch), working in the NSW Attorney’s General Department as Director of Crime Prevention, working with cabinet ministers and as a non-executive director on a number of Boards.

Dr Jarratt advised that Steven brings exceptionally strong skills and capacity in the areas of leadership, management, networking, partnership, engaging political engagement, advocacy, communication, strategic management and strategy development.
Steven will be working with outgoing CEO Stuart Loveday during a short handover period. Stuart has confirmed he will formally retire from Hepatitis NSW on 29 October 2019.

Stuart leaves with our heartfelt thanks and appreciation for 25 years of incredible service to Hepatitis NSW and to the communities of people affected by hepatitis C and hepatitis B in NSW.


  1. REPLY
    greg ball says

    the last person i would want to lead hepatitis councils is a member of the pharmaceutical company`s that gave us this disease, your joking right ?

    • REPLY
      Grace Crowley says

      Hi Greg – Thanks for your post. The Pharmaceutical Society of Australia (and its State and Territory branches) have nothing to do with pharmaceutical companies or the pharmaceutical industry. PSA is the only Australian Government-recognised peak national professional pharmacy organisation representing all of Australia’s 31,000 pharmacists working in all sectors and across all locations psa.org.au
      We are delighted that Steven Drew is joining Hepatitis NSW as our new CEO. Steven brings a wealth of experience he has gained in leadership positions in the community, NGO and government sectors. Please contact us if you would like more information.
      Stuart Loveday
      CEO Hepatitis NSW

Post a comment